Biochemical and molecular characterization of three new variants of AmpC β-lactamases from Morganella morganii

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 3, 2006, Pages 962-967

  Power, Pablo ^a,b   Galleni, Moreno ^b   Ayala, Juan A ^c   Gutkind, Gabriel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINOPENICILLANIC ACID; AZTREONAM; BETA LACTAMASE AMPC; CARBENICILLIN; CEFOTAXIME; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; PENICILLIN G; TAZOBACTAM;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMPC GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CATALYSIS; CONTROLLED STUDY; DNA BINDING; GENE SEQUENCE; HYDROLYSIS; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; BINDING SITES; DNA; GENES, BACTERIAL; HELIX-TURN-HELIX MOTIFS; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; KINETICS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MORGANELLA MORGANII; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

EID: 33644649572     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.3.962-967.2006     Document Type: Article

References (39)

1. Akova, M., Y. Yang, and D. M. Livermore. 1990. Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed class I β-lactamases. J. Antimicrob. Chemother. 25:199-208.
2. Alvarez, M., J. H. Tran, N. Chow, and G. A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.
3. Barnaud, G., G. Arlet, C. Danglot, and A. Philippon. 1997. Cloning and sequencing of the gene encoding the AmpC β-lactamase of Morganella morganii. FEMS Microbiol. Lett. 148:15-20.
4. Barnaud, G., G. Arlet, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippon. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352-2358.
5. Bartowsky, E., and S. Normark. 1993. Interactions of wild-type and mutant AmpR of Citrobacter freundii with target DNA. Mol. Microbiol. 10:555-565.
6. Bekal, S., J. van Beeumen, B. Samyn, D. Garmyn, S. Henini, C. Diviès, and H. Prévost. 1998. Purification of Leuconostoc mesenteroides citrate lyase and cloning and characterization of the citCDEFG gene cluster. J. Bacteriol. 180:647-654.
7. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
8. De Meester, F., B. Joris, G. Reckinger, C. Bellefroid-Bourguignon, J. M. Frère, and S. G. Waley. 1987. Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and DD-peptidases. Biochem. Pharmacol. 36:2393-2403.
9. Eliopoulos, G. M. 1988. Induction of β-lactamases. J. Antimicrob. Chemother. 22:37-44.
10. Everett, M., T. Walsh, G. Guay, and P. Bennett. 1995. GevA, a LysR-type transcriptional regulator protein, activates expression of the cloned Citrobacter freundii ampC β-lactamase gene in Escherichia coli: cross-talk between DNA-binding proteins. Microbiology 141:419-430.
11. Fortineau, N., L. Poirel, and P. Nordmann. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207-210.
12. Gaillot, O., C. Clement, M. Simonet, and A. Philippon. 1997. Novel transferable β-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 39:85-87.
13. Galleni, M., G. Amicosante, and J.-M. Frère. 1988. A survey of the kinetic parameters of class C β-lactamases. Cephalosporins and other β-lactam compounds. Biochem. J. 255:123-129.
14. Galleni, M., and J.-M. Frère. 1988. A survey of the kinetic parameters of class C β-lactamases. Penicillins. Biochem. J. 255:119-122.
15. Gerhardt, P., R. G. E. Murray, W. A. Wood, and N. R. Krieg. 1994. Methods for general and molecular bacteriology. ASM Press, Washington, D.C.
16. Ghuysen, J. M. 1991. Serine β-lactamases and penicillin-binding- proteins. Annu. Rev. Microbiol. 45:37-67.
17. Hames, B. D. 1981. An introduction to polyacrylamide gel electrophoresis. In B. D. Hames and D. Rickwood (ed.), Gel electrophoresis of proteins: a practical approach. IRL Press, Oxford, United Kingdom.
18. Jacobs, C., J.-M. Frère, and S. Normark. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in Gram-negative bacteria. Cell 88:823-832.
19. Liebana, E., M. Batchelor, F. A. Clifton-Hadley, R. H. Davies, K. L. Hopkins, and E. J. Threlfall. 2004. First report of Salmonella isolates with the DHA-1 AmpC β-lactamase in the United Kingdom. Antimicrob. Agents Chemother. 48:4492.
20. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
21. Matagne, A., A. Dubus, M. Galleni, and J.-M. Frère. 1999. The β-lactamase cycle: a tale of selective pressure and bacterial ingenuity. Nat. Prod. Rep. 16:1-19.
22. Matagne, A., J. Lamotte-Brasseur, G. Dive, J. R. Knox, and J. M. Frère. 1993. Interactions between active-site serine β-lactamases and compounds bearing a methoxy side chain on the α-face of the β-lactam ring: kinetic and molecular modelling studies. Biochem. J. 293:607-611.
23. Matagne, A., J. Lamotte-Brasseur, and J.-M. Frère. 1998. Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem. J. 330:581-598.
24. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
25. Muñoz, V., and L. Serrano. 1997. Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. Biopolymers 41:495-509.
26. Naas, T., D. M. Livermore, and P. Nordmann. 1995. Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing β-lactamase Sme-1, and comparison of this regulator with other β-lactamase regulators. Antimicrob. Agents Chemother. 39:629-637.
27. Naas, T., and P. Nordmann. 1994. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl. Acad. Sci. USA 91:7693-7697.
28. Nakano, Y., Y. Yoshida, Y. Yamashita, and T. Koga. 1995. Construction of a series of pACYC-derived plasmid vectors. Gene 162:157-158.
29. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed., vol. 20. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
30. Nielsen, H., J. Engelbrecht, S. Brunak, and G. von Heijne. 1997. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1-6.
31. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analysis, expression, and distribution of ampC·ampR from Morganella morganii. Antimicrob Agents Chemother. 43:769-776.
32. Power, P., M. Radice, C. Barberis, C. de Mier, M. Mollerach, M. Maltagliatti, C. Vay, A. Famiglietti, and G. Gutkind. 1999. Cefotaxime- hydrolysing β-lactamases in Morganella morganii. Eur. J. Clin. Microbiol. Infect. Dis. 18:743-747.
33. Sambrook, J., E. F. Fristch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Sanger, I., S. Nicklen, and A. Coulson. 1977. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
35. Schwede, T., J. Kopp, N. Guex, and M. C. Peitsch. 2003. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31:3381-3385.
36. Toda, M., M. Inoue, and S. Mitsuhashi. 1981. Properties of cephalosporinase from Proteus morganii. J. Antibiot. 34:1469-1475.
37. Yan, J.-J., W.-C. Ko, Y.-C. Jung, C.-L. Chuang, and J.-J. Wu. 2002. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J. Clin. Microbiol. 40:3121-3126.
38. Yang, Y., and D. M. Livermore. 1988. Chromosomal β-lactamase expression and resistance to β-lactam antibiotics in Proteus vulgaris and Morganella morganii. Antimicrob. Agents Chemother. 32:1385-1391.
39. Yong, D., Y. Lim, W. Song, Y. S. Choi, D.-Y. Park, H. Lee, J. H. Yum, K. Lee, J. M. Kim, and Y. Chong. 2005. Plasmid-mediated, inducible AmpC β-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis. Diagn. Microbiol. Infect. Dis. 53:65-70.